Haemophilus influenzae B Ab:MCnc:Pt:Ser:Qn

The epidemiology of invasive Haemophilus influenzae infections was evaluated in Ontario between 1989 and 2007 to assess the… Expand

OBJECTIVE. New vaccines that offer protection against otitis media caused by nontypeable Haemophilus influenzae and by Moraxella… Expand

BACKGROUND The generalization of the vaccination against H. influenzae b (Hib), according to its integration in the French… Expand

For a seven year period (1985-91) clinical and epidemiological data were prospectively collected on children aged < 10 years with… Expand

OBJECTIVE To evaluate the immunologic potential of infants 7 to 15 months of age to respond to Haemophilus influenzae type b… Expand

Induction of surface Mac-1 by inflammatory stimuli is fundamental to a broad spectrum of granulocyte adherence reactions. To… Expand

Twenty-six healthy children previously immunized (imm) with the Hib capsular polysaccharide (Hib CP) vaccine at age 19 to 38 mos… Expand

Hemophilus influenzae type b (HIB) is the leading cause of bacterial meningitis in the United States. Efforts are under way to… Expand

A long-term follow-up of approximately 50,000 children who received the Hemophilus influenzae type b capsular polysaccharide… Expand

An intranasal immunization with a A/PR8/34-isolated NA, protected mice as well as the whole virus and A/Hong Kong/1/68 virus… Expand